Alessandro Del Conte

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 8

Top Topics

Tyrosine Kinase

Epidermal Growth Factor Receptor

Small Cell Lung Cancer

Top Venues

International journal of molecular sciences

Future oncology (London, England)

This page only lists publications with an associated author ORCID identifier.

Publications

Elisa Bertoli, Elisa De Carlo, Martina Bortolot, Brigida Stanzione, Alessandro Del Conte, Michele Spina, Alessandra Bearz
Targeted Therapy in Mesotheliomas: Uphill All the Way. Cancers 16 (11) (2024)
Elisa Bertoli, Elisa De Carlo, Martina Bortolot, Brigida Stanzione, Alessandro Del Conte, Michele Spina, Alessandra Bearz
Targeted Therapy in Mesotheliomas: Uphill All the Way. Cancers 16 (11) (2024)
Brigida Stanzione, Alessandro Del Conte, Elisa Bertoli, Elisa De Carlo, Alberto Revelant, Michele Spina, Alessandra Bearz
Therapeutical Options in ROS1-Rearranged Advanced Non Small Cell Lung Cancer. International journal of molecular sciences 24 (14) (2023)
Elisa Bertoli, Elisa De Carlo, Debora Basile, Diego Zara, Brigida Stanzione, Monica Schiappacassi, Alessandro Del Conte, Michele Spina, Alessandra Bearz
Liquid Biopsy in NSCLC: An Investigation with Multiple Clinical Implications. International journal of molecular sciences 24 (13) (2023)
Andrea Camerini, Alessandro Del Conte, Aldo Pezzuto, Vieri Scotti, Francesco Facchinetti, Lucia Pia Ciccone, Marco Perna, Giulia Sartori, Cheti Puccetti, Alberto Ricci, Antonio Santo, Marcello Tiseo, Domenico Amoroso
Selection Criteria and Treatment Outcome for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Unfit for Platinum-Based First-Line Therapy: Results of the MOON-OSS Observational Trial. Cancers 14 (24) (2022)
Andrea Camerini, Alessandro Del Conte, Aldo Pezzuto, Vieri Scotti, Francesco Facchinetti, Lucia Pia Ciccone, Marco Perna, Giulia Sartori, Cheti Puccetti, Alberto Ricci, Antonio Santo, Marcello Tiseo, Domenico Amoroso
Selection Criteria and Treatment Outcome for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Unfit for Platinum-Based First-Line Therapy: Results of the MOON-OSS Observational Trial. Cancers 14 (24) (2022)
Andrea Camerini, Alessandro Del Conte, Aldo Pezzuto, Vieri Scotti, Francesco Facchinetti, Lucia Pia Ciccone, Marco Perna, Giulia Sartori, Cheti Puccetti, Alberto Ricci, Antonio Santo, Marcello Tiseo, Domenico Amoroso
Selection Criteria and Treatment Outcome for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Unfit for Platinum-Based First-Line Therapy: Results of the MOON-OSS Observational Trial. Cancers 14 (24) (2022)
Alessandro Dal Maso, Martina Lorenzi, Alessandra Ferro, Sara Pilotto, Fabiana Cecere, Alessandro Follador, Valentina Polo, Alessandro Del Conte, Giulia Sartori, Marco Giavarra, Daniela Scattolin, Stefano Indraccolo, Stefano Frega, Giovanna De Maglio, Jessica Menis, Laura Bonanno, Fiorella Calabrese, Valentina Guarneri, PierFranco Conte, Giulia Pasello
Real-world data on treatment outcomes in EGFR-mutant non-small-cell lung cancer patients receiving osimertinib in second or further lines. Future oncology (London, England) 17 (19) (2021)